ANI intros generic Carnitor
Generic Carnitor is used for the treatment of primary systemic carnitine deficiency.
ANI is offering levocarnitine tablets, 330 mg, which are the generic version of Leadiant Biosciences’ Carnitor.
The medication is indicated for the treatment of primary systemic carnitine deficiency.
Levocarnitine tablets have a market value of approximately $10 million, according to IQVIA.
[Read more: ANI intros generic Compazine]
"The launch of levocarnitine tablets is another example of ANI’s commitment to increasing patient access to affordable, high-quality medicines and aligns with our goal of bringing limited-competition products to market,” said Nikhil Lalwani, president and CEO of ANI.